Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemoperfusion Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Hemoperfusion Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-10
Pages: 120 Pages
Report ld: 5036190
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemoperfusion Market Size(US$)
CAGR 2025-2031
18.1%
Market Size,2031
USD 2,199
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 811 million
Market Forecast in 2031(Value)
US$ 2,199 million
CAGR
18.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemoperfusion market is projected to grow from US$ 697 million in 2024 to US$ 2199 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
The hemoperfusion market is experiencing growing interest as healthcare providers increasingly adopt advanced blood purification techniques to manage various critical conditions, including drug overdoses, sepsis, and autoimmune diseases. Hemoperfusion, which involves passing blood through an adsorbent-containing cartridge to remove toxins, offers targeted and efficient detoxification that traditional dialysis cannot always achieve. This capability makes it particularly valuable in emergency care and intensive care settings, driving its adoption in hospitals and specialized clinics worldwide.
Additionally, technological advancements in cartridge materials and the integration of hemoperfusion with other extracorporeal therapies are enhancing the efficacy and safety of treatments. As awareness of its clinical benefits spreads and regulatory support strengthens, more healthcare systems in both developed and emerging markets are incorporating hemoperfusion into standard care protocols. However, market growth may still face challenges such as limited practitioner familiarity and cost considerations, which need to be addressed through education and innovation.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Hemoperfusion market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Jianfan Biotech
- Kangbei Medical
- Foshan Boxin (Lily Medical)
- Baxter
- Asahi Kasei
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Activated Carbon Adsorption
- Resin Adsorption
Segment by Application
- Hepatic Encephalopathy
- Certain Autoimmune Diseases
- Drug Overdose
- Specific Intoxications
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Hemoperfusion study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Hemoperfusion: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hemoperfusion Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Market Segmentation by Application
1.3.1 Global Hemoperfusion Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hepatic Encephalopathy
1.3.3 Certain Autoimmune Diseases
1.3.4 Drug Overdose
1.3.5 Specific Intoxications
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hemoperfusion Revenue Estimates and Forecasts 2020-2031
2.2 Global Hemoperfusion Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Hemoperfusion Sales Estimates and Forecasts 2020-2031
2.4 Global Hemoperfusion Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Hemoperfusion Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Hemoperfusion Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Activated Carbon Adsorption Market Size by Manufacturers
3.5.2 Resin Adsorption Market Size by Manufacturers
3.6 Global Hemoperfusion Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Hemoperfusion Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Hemoperfusion Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Hemoperfusion Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hemoperfusion Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Hemoperfusion Sales and Revenue by Type (2020-2031)
6.4 North America Hemoperfusion Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Hemoperfusion Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Hemoperfusion Sales and Revenue by Type (2020-2031)
7.4 Europe Hemoperfusion Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Hemoperfusion Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Hemoperfusion Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Hemoperfusion Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Hemoperfusion Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Hemoperfusion Sales and Revenue by Type (2020-2031)
9.4 Central and South America Hemoperfusion Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Hemoperfusion Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Hemoperfusion Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Hemoperfusion Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Hemoperfusion Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Jianfan Biotech
11.1.1 Jianfan Biotech Corporation Information
11.1.2 Jianfan Biotech Business Overview
11.1.3 Jianfan Biotech Hemoperfusion Product Models, Descriptions and Specifications
11.1.4 Jianfan Biotech Hemoperfusion Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Jianfan Biotech Hemoperfusion Sales by Product in 2024
11.1.6 Jianfan Biotech Hemoperfusion Sales by Application in 2024
11.1.7 Jianfan Biotech Hemoperfusion Sales by Geographic Area in 2024
11.1.8 Jianfan Biotech Hemoperfusion SWOT Analysis
11.1.9 Jianfan Biotech Recent Developments
11.2 Kangbei Medical
11.2.1 Kangbei Medical Corporation Information
11.2.2 Kangbei Medical Business Overview
11.2.3 Kangbei Medical Hemoperfusion Product Models, Descriptions and Specifications
11.2.4 Kangbei Medical Hemoperfusion Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Kangbei Medical Hemoperfusion Sales by Product in 2024
11.2.6 Kangbei Medical Hemoperfusion Sales by Application in 2024
11.2.7 Kangbei Medical Hemoperfusion Sales by Geographic Area in 2024
11.2.8 Kangbei Medical Hemoperfusion SWOT Analysis
11.2.9 Kangbei Medical Recent Developments
11.3 Foshan Boxin (Lily Medical)
11.3.1 Foshan Boxin (Lily Medical) Corporation Information
11.3.2 Foshan Boxin (Lily Medical) Business Overview
11.3.3 Foshan Boxin (Lily Medical) Hemoperfusion Product Models, Descriptions and Specifications
11.3.4 Foshan Boxin (Lily Medical) Hemoperfusion Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Foshan Boxin (Lily Medical) Hemoperfusion Sales by Product in 2024
11.3.6 Foshan Boxin (Lily Medical) Hemoperfusion Sales by Application in 2024
11.3.7 Foshan Boxin (Lily Medical) Hemoperfusion Sales by Geographic Area in 2024
11.3.8 Foshan Boxin (Lily Medical) Hemoperfusion SWOT Analysis
11.3.9 Foshan Boxin (Lily Medical) Recent Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Business Overview
11.4.3 Baxter Hemoperfusion Product Models, Descriptions and Specifications
11.4.4 Baxter Hemoperfusion Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Baxter Hemoperfusion Sales by Product in 2024
11.4.6 Baxter Hemoperfusion Sales by Application in 2024
11.4.7 Baxter Hemoperfusion Sales by Geographic Area in 2024
11.4.8 Baxter Hemoperfusion SWOT Analysis
11.4.9 Baxter Recent Developments
11.5 Asahi Kasei
11.5.1 Asahi Kasei Corporation Information
11.5.2 Asahi Kasei Business Overview
11.5.3 Asahi Kasei Hemoperfusion Product Models, Descriptions and Specifications
11.5.4 Asahi Kasei Hemoperfusion Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Asahi Kasei Hemoperfusion Sales by Product in 2024
11.5.6 Asahi Kasei Hemoperfusion Sales by Application in 2024
11.5.7 Asahi Kasei Hemoperfusion Sales by Geographic Area in 2024
11.5.8 Asahi Kasei Hemoperfusion SWOT Analysis
11.5.9 Asahi Kasei Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hemoperfusion Industry Chain
12.2 Hemoperfusion Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hemoperfusion Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hemoperfusion Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hemoperfusion Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Hemoperfusion Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Hemoperfusion Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Hemoperfusion Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Hemoperfusion Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Hemoperfusion Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Hemoperfusion Sales by Region (2020-2025) & (K Units)
Table 8. Global Hemoperfusion Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Hemoperfusion Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Hemoperfusion Sales Share by Manufacturers (2020-2025)
Table 12. Global Hemoperfusion Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Hemoperfusion Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Hemoperfusion by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2024)
Table 16. Global Hemoperfusion Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Hemoperfusion Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Unit)
Table 18. Key Manufacturers Hemoperfusion Manufacturing Base and Headquarters
Table 19. Global Hemoperfusion Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Hemoperfusion Sales by Type (2020-2025) & (K Units)
Table 23. Global Hemoperfusion Sales by Type (2026-2031) & (K Units)
Table 24. Global Hemoperfusion Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Hemoperfusion Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Hemoperfusion ASP by Type (2020-2031) & (USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Hemoperfusion Sales by Application (2020-2025) & (K Units)
Table 29. Global Hemoperfusion Sales by Application (2026-2031) & (K Units)
Table 30. Hemoperfusion High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Hemoperfusion Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Hemoperfusion Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Hemoperfusion ASP by Application (2020-2031) & (USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Hemoperfusion Growth Accelerators and Market Barriers
Table 37. North America Hemoperfusion Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Hemoperfusion Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Hemoperfusion Growth Accelerators and Market Barriers
Table 40. Europe Hemoperfusion Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Hemoperfusion Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Hemoperfusion Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Hemoperfusion Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Hemoperfusion Growth Accelerators and Market Barriers
Table 45. Southeast Asia Hemoperfusion Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Hemoperfusion Investment Opportunities and Key Challenges
Table 47. Central and South America Hemoperfusion Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Hemoperfusion Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Hemoperfusion Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Jianfan Biotech Corporation Information
Table 51. Jianfan Biotech Description and Major Businesses
Table 52. Jianfan Biotech Product Models, Descriptions and Specifications
Table 53. Jianfan Biotech Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 54. Jianfan Biotech Sales Value Proportion by Product in 2024
Table 55. Jianfan Biotech Sales Value Proportion by Application in 2024
Table 56. Jianfan Biotech Sales Value Proportion by Geographic Area in 2024
Table 57. Jianfan Biotech Hemoperfusion SWOT Analysis
Table 58. Jianfan Biotech Recent Developments
Table 59. Kangbei Medical Corporation Information
Table 60. Kangbei Medical Description and Major Businesses
Table 61. Kangbei Medical Product Models, Descriptions and Specifications
Table 62. Kangbei Medical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Kangbei Medical Sales Value Proportion by Product in 2024
Table 64. Kangbei Medical Sales Value Proportion by Application in 2024
Table 65. Kangbei Medical Sales Value Proportion by Geographic Area in 2024
Table 66. Kangbei Medical Hemoperfusion SWOT Analysis
Table 67. Kangbei Medical Recent Developments
Table 68. Foshan Boxin (Lily Medical) Corporation Information
Table 69. Foshan Boxin (Lily Medical) Description and Major Businesses
Table 70. Foshan Boxin (Lily Medical) Product Models, Descriptions and Specifications
Table 71. Foshan Boxin (Lily Medical) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Foshan Boxin (Lily Medical) Sales Value Proportion by Product in 2024
Table 73. Foshan Boxin (Lily Medical) Sales Value Proportion by Application in 2024
Table 74. Foshan Boxin (Lily Medical) Sales Value Proportion by Geographic Area in 2024
Table 75. Foshan Boxin (Lily Medical) Hemoperfusion SWOT Analysis
Table 76. Foshan Boxin (Lily Medical) Recent Developments
Table 77. Baxter Corporation Information
Table 78. Baxter Description and Major Businesses
Table 79. Baxter Product Models, Descriptions and Specifications
Table 80. Baxter Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Baxter Sales Value Proportion by Product in 2024
Table 82. Baxter Sales Value Proportion by Application in 2024
Table 83. Baxter Sales Value Proportion by Geographic Area in 2024
Table 84. Baxter Hemoperfusion SWOT Analysis
Table 85. Baxter Recent Developments
Table 86. Asahi Kasei Corporation Information
Table 87. Asahi Kasei Description and Major Businesses
Table 88. Asahi Kasei Product Models, Descriptions and Specifications
Table 89. Asahi Kasei Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Asahi Kasei Sales Value Proportion by Product in 2024
Table 91. Asahi Kasei Sales Value Proportion by Application in 2024
Table 92. Asahi Kasei Sales Value Proportion by Geographic Area in 2024
Table 93. Asahi Kasei Hemoperfusion SWOT Analysis
Table 94. Asahi Kasei Recent Developments
Table 95. Key Raw Materials Distribution
Table 96. Raw Materials Key Suppliers
Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 98. Milestones in Production Technology Evolution
Table 99. Distributors List
Table 100. Market Trends and Market Evolution
Table 101. Market Drivers and Opportunities
Table 102. Market Challenges, Risks, and Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemoperfusion Product Picture
Figure 2. Global Hemoperfusion Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Activated Carbon Adsorption Product Picture
Figure 4. Resin Adsorption Product Picture
Figure 5. Global Hemoperfusion Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hepatic Encephalopathy
Figure 7. Certain Autoimmune Diseases
Figure 8. Drug Overdose
Figure 9. Specific Intoxications
Figure 10. Others
Figure 11. Hemoperfusion Report Years Considered
Figure 12. Global Hemoperfusion Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 14. Global Hemoperfusion Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Hemoperfusion Revenue Market Share by Region (2020-2031)
Figure 16. Global Hemoperfusion Sales (2020-2031) & (K Units)
Figure 17. Global Hemoperfusion Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Hemoperfusion Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Hemoperfusion Sales Volume Market Share in 2024
Figure 20. Global Hemoperfusion Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Activated Carbon Adsorption Revenue Market Share by Manufacturer in 2024
Figure 23. Resin Adsorption Revenue Market Share by Manufacturer in 2024
Figure 24. Global Hemoperfusion Sales Market Share by Type (2020-2031)
Figure 25. Global Hemoperfusion Revenue Market Share by Type (2020-2031)
Figure 26. Global Hemoperfusion Sales Market Share by Application (2020-2031)
Figure 27. Global Hemoperfusion Revenue Market Share by Application (2020-2031)
Figure 28. North America Hemoperfusion Sales YoY (2020-2031) & (K Units)
Figure 29. North America Hemoperfusion Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Hemoperfusion Sales Revenue (US$ Million) in 2024
Figure 31. North America Hemoperfusion Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Hemoperfusion Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Hemoperfusion Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Hemoperfusion Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Hemoperfusion Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Hemoperfusion Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Hemoperfusion Sales Revenue (US$ Million) in 2024
Figure 41. Europe Hemoperfusion Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Hemoperfusion Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Hemoperfusion Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Hemoperfusion Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 46. France Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Hemoperfusion Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Hemoperfusion Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Hemoperfusion Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Hemoperfusion Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Hemoperfusion Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Hemoperfusion Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Hemoperfusion Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 61. India Hemoperfusion Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Hemoperfusion Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Hemoperfusion Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Hemoperfusion Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Hemoperfusion Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Hemoperfusion Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Hemoperfusion Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Hemoperfusion Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Hemoperfusion Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Hemoperfusion Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Hemoperfusion Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Hemoperfusion Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Hemoperfusion Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Hemoperfusion Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Hemoperfusion Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Hemoperfusion Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Hemoperfusion Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Hemoperfusion Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Hemoperfusion Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Hemoperfusion Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Hemoperfusion Revenue (2020-2025) & (US$ Million)
Figure 82. Hemoperfusion Industry Chain Mapping
Figure 83. Regional Hemoperfusion Manufacturing Base Distribution (%)
Figure 84. Global Hemoperfusion Production Market Share by Region (2020-2031)
Figure 85. Hemoperfusion Production Process
Figure 86. Regional Hemoperfusion Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hemoperfusion market size from 2025 to 2031?
The annual compound growth rate of the global Hemoperfusion market is 18.1% 2025 to 2031.
What was the global market size of Hemoperfusion in 2031?
What was the global market size of Hemoperfusion in 2025?
Which companies rank high in the global Hemoperfusion market?
Which region is expected to have the highest market share?
Related Reports
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemoperfusion market size was US$ 478 million in 2025 and is forecast to reach a readjusted size of US$ 814 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 67
USD 4250.00
(Single User License)
Global Hemoperfusion Market Research Report 2026
The global Hemoperfusion market was valued at US$ 478 million in 2025 and is anticipated to reach US$ 814 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 104
USD 2900.00
(Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemoperfusion was estimated to be worth US$ 478 million in 2025 and is projected to reach US$ 814 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 82
USD 3950.00
(Single User License)
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemoperfusion market size was US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 74
USD 4250.00
(Single User License)
Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-07-02
Pages: 84
USD 3950.00
(Single User License)
Global Hemoperfusion Market Insights, Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 811 million in 2025 to US$ 2199 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period.
Published Date: 2025-07-02
Pages: 118
USD 4900.00
(Single User License)
Global Hemoperfusion Market Research Report 2025
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published Date: 2025-07-02
Pages: 72
USD 2900.00
(Single User License)
Global Hemoperfusion Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemoperfusion was estimated to be worth US$ 697 million and is forecast to reach approximately US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 130
USD 5900.00
(Single User License)
Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 100
USD 3950.00
(Single User License)
Global Hemoperfusion Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Published Date: 2024-04-17
Pages: 135
USD 5600.00
(Single User License)
Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemoperfusion market size was US$ 478 million in 2025 and is forecast to reach a readjusted size of US$ 814 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 67
USD 4250.00 (Single User License)Global Hemoperfusion Market Research Report 2026
The global Hemoperfusion market was valued at US$ 478 million in 2025 and is anticipated to reach US$ 814 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 104
USD 2900.00 (Single User License)Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemoperfusion was estimated to be worth US$ 478 million in 2025 and is projected to reach US$ 814 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 82
USD 3950.00 (Single User License)Global Hemoperfusion Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemoperfusion market size was US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 74
USD 4250.00 (Single User License)Hemoperfusion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-07-02
Pages: 84
USD 3950.00 (Single User License)Global Hemoperfusion Market Insights, Forecast to 2031
The global Hemoperfusion market is projected to grow from US$ 811 million in 2025 to US$ 2199 million by 2031, at a Compound Annual Growth Rate (CAGR) of 18.1% during the forecast period.
Published: 2025-07-02
Pages: 118
USD 4900.00 (Single User License)Global Hemoperfusion Market Research Report 2025
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published: 2025-07-02
Pages: 72
USD 2900.00 (Single User License)Global Hemoperfusion Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemoperfusion was estimated to be worth US$ 697 million and is forecast to reach approximately US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 130
USD 5900.00 (Single User License)Hemoperfusion- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 100
USD 3950.00 (Single User License)Global Hemoperfusion Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Published: 2024-04-17
Pages: 135
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now